<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39444888</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2072-1439</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of thoracic disease</Title><ISOAbbreviation>J Thorac Dis</ISOAbbreviation></Journal><ArticleTitle>Increased risk of pulmonary embolism and deep vein thrombosis with COVID-19 pneumonia in comparison to influenza pneumonia: insights from the National Inpatient Sample database.</ArticleTitle><Pagination><StartPage>6161</StartPage><EndPage>6170</EndPage><MedlinePgn>6161-6170</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/jtd-23-1674</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily a respiratory virus causing coronavirus disease 2019 (COVID-19) pneumonia, induces a hypercoagulable state. Previous studies comparing the prevalence of venous thromboembolism (VTE) in patients with COVID-19 pneumonia and those with influenza pneumonia revealed a higher risk of pulmonary embolism (PE) and deep vein thrombosis (DVT) associated with COVID-19 pneumonia. However, these studies have not adequately accounted for the severity and acuity of the presenting viral pneumonia.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this retrospective study, we rigorously adjusted for critical illness using a nationally representative dataset to investigate whether COVID-19 pneumonia is independently linked to a higher risk of PE and DVT.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">After comprehensive multivariate adjustment, our findings demonstrated that patients with COVID-19 pneumonia maintained significantly higher odds of developing acute inpatient PE [adjusted odds ratio (aOR): 2.48; 95% confidence interval (CI): 2.16-2.86; P&lt;0.01] and DVT (aOR: 1.66; 95% CI: 1.41-1.96; P&lt;0.01) during the early pandemic compared to patients with influenza pneumonia. Furthermore, we identified congenital heart disease and malnutrition as novel risk factors for acute PE in COVID-19 patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our study suggests that the higher prevalence of acute inpatient PE over DVT in patients with COVID-19 pneumonia may support a "thrombus <i>in situ</i>" mechanism of SARS-CoV-2-mediated pulmonary thrombosis. Consequently, clinicians should maintain a high index of suspicion for PE, even in the absence of DVT, among patients with COVID-19 pneumonia and should follow evidence-based guidelines for diagnosis and management.</AbstractText><CopyrightInformation>2024 AME Publishing Company. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Raj</LastName><ForeName>Kavin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3184-4380</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of California Riverside School of Medicine, Riverside, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Majeed</LastName><ForeName>Harris</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandna</LastName><ForeName>Sanya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0260-8039</Identifier><AffiliationInfo><Affiliation>Department of Hospital Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitkara</LastName><ForeName>Akshit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of California Riverside School of Medicine, Riverside, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Abu Baker</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Ashish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cleveland Clinic Akron General, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangu</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pillai</LastName><ForeName>Keerthana Jyotheeswara</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of California Riverside School of Medicine, Riverside, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Ankit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadashiv</LastName><ForeName>Santhosh K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Hematology and Oncology, West Penn Hospital, Alleghany Health Network, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Ankur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Thorac Dis</MedlineTA><NlmUniqueID>101533916</NlmUniqueID><ISSNLinking>2072-1439</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus disease 2019 (COVID-19)</Keyword><Keyword MajorTopicYN="N">deep vein thrombosis (DVT)</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">pulmonary embolism (PE)</Keyword><Keyword MajorTopicYN="N">venous thromboembolism (VTE)</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1674/coif). The series “Thoracic Diseases and Big Data” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39444888</ArticleId><ArticleId IdType="pmc">PMC11494551</ArticleId><ArticleId IdType="doi">10.21037/jtd-23-1674</ArticleId><ArticleId IdType="pii">jtd-16-09-6161</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spiezia L, Boscolo A, Poletto F, et al. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost 2020;120:998-1000. 10.1055/s-0040-1710018</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710018</ArticleId><ArticleId IdType="pmc">PMC7295272</ArticleId><ArticleId IdType="pubmed">32316063</ArticleId></ArticleIdList></Reference><Reference><Citation>Poissy J, Goutay J, Caplan M, et al. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation 2020;142:184-6. 10.1161/CIRCULATIONAHA.120.047430</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047430</ArticleId><ArticleId IdType="pubmed">32330083</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med 2018;378:345-53. 10.1056/NEJMoa1702090</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1702090</ArticleId><ArticleId IdType="pubmed">29365305</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehme AK, Luna J, Kulick ER, et al. Influenza-like illness as a trigger for ischemic stroke. Ann Clin Transl Neurol 2018;5:456-63. 10.1002/acn3.545</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.545</ArticleId><ArticleId IdType="pmc">PMC5899905</ArticleId><ArticleId IdType="pubmed">29687022</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunce PE, High SM, Nadjafi M, et al. Pandemic H1N1 influenza infection and vascular thrombosis. Clin Infect Dis 2011;52:e14-7. 10.1093/cid/ciq125</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciq125</ArticleId><ArticleId IdType="pubmed">21288835</ArticleId></ArticleIdList></Reference><Reference><Citation>Stals MAM, Grootenboers MJJH, van Guldener C, et al. Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients. Res Pract Thromb Haemost 2021;5:412-20. 10.1002/rth2.12496</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12496</ArticleId><ArticleId IdType="pmc">PMC8014477</ArticleId><ArticleId IdType="pubmed">33821230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Re V, 3rd, Dutcher SK, Connolly JG, et al. Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients. JAMA 2022;328:637-51. 10.1001/jama.2022.13072</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.13072</ArticleId><ArticleId IdType="pmc">PMC9382447</ArticleId><ArticleId IdType="pubmed">35972486</ArticleId></ArticleIdList></Reference><Reference><Citation>AHRQ. National (Nationwide) Inpatient Sample (NIS) Database Documentation. 2022. Accessed October 17, 2022. Available online: https://hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp</Citation></Reference><Reference><Citation>Hotoleanu C. Association between obesity and venous thromboembolism. Med Pharm Rep 2020;93:162-8. 10.15386/mpr-1372</Citation><ArticleIdList><ArticleId IdType="doi">10.15386/mpr-1372</ArticleId><ArticleId IdType="pmc">PMC7243888</ArticleId><ArticleId IdType="pubmed">32478322</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Goldhaber SZ, Kroll A, et al. Venous thromboembolism in patients with diabetes mellitus. Am J Med 2012;125:709-16. 10.1016/j.amjmed.2011.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2011.12.004</ArticleId><ArticleId IdType="pmc">PMC3424058</ArticleId><ArticleId IdType="pubmed">22560173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics (Basel) 2022;12:2757. 10.3390/diagnostics12112757</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12112757</ArticleId><ArticleId IdType="pmc">PMC9689150</ArticleId><ArticleId IdType="pubmed">36428817</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj K, Yeruva K, Jyotheeswara Pillai K, et al. Population Risk Factors for Severe Disease and Mortality in COVID-19 in the United States during the Pre-Vaccine Era: A Retrospective Cohort Study of National Inpatient Sample. Med Sci (Basel) 2022;10:67. 10.3390/medsci10040067</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medsci10040067</ArticleId><ArticleId IdType="pmc">PMC9788467</ArticleId><ArticleId IdType="pubmed">36548002</ArticleId></ArticleIdList></Reference><Reference><Citation>Minet C, Potton L, Bonadona A, et al. Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis. Crit Care 2015;19:287. 10.1186/s13054-015-1003-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1003-9</ArticleId><ArticleId IdType="pmc">PMC4539929</ArticleId><ArticleId IdType="pubmed">26283414</ArticleId></ArticleIdList></Reference><Reference><Citation>Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006;367:1075-9. 10.1016/S0140-6736(06)68474-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68474-2</ArticleId><ArticleId IdType="pubmed">16581406</ArticleId></ArticleIdList></Reference><Reference><Citation>Tichelaar YI, Kluin-Nelemans HJ, Meijer K. Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb Haemost 2012;107:827-37. 10.1160/TH11-09-0611</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH11-09-0611</ArticleId><ArticleId IdType="pubmed">22437808</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Levy JH, Levi M, et al. Coagulopathy of Coronavirus Disease 2019. Crit Care Med 2020;48:1358-64. 10.1097/CCM.0000000000004458</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004458</ArticleId><ArticleId IdType="pmc">PMC7255402</ArticleId><ArticleId IdType="pubmed">32467443</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020;395:1417-8. 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020;383:120-8. 10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj K, Chandna S, Doukas SG, et al. Combined Use of Wells Scores and D-dimer Levels for the Diagnosis of Deep Vein Thrombosis and Pulmonary Embolism in COVID-19: A Retrospective Cohort Study. Cureus 2021;13:e17687. 10.7759/cureus.17687</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.17687</ArticleId><ArticleId IdType="pmc">PMC8487632</ArticleId><ArticleId IdType="pubmed">34650862</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>